查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1980011

行為表現型分析人工智慧市場預測：至 2034 年—按解決方案類型、組件、部署模式、技術、應用、最終用戶和地區分類的全球分析

Behavioral Phenotyping AI Market Forecasts to 2034 - Global Analysis By Solution Type, Component, Deployment, Technology, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的研究，全球行為表現型分析 AI 市場預計將在 2026 年達到 93 億美元，並在預測期內以 14.8% 的複合年成長率成長，到 2034 年達到 281 億美元。

行為表現型分析人工智慧是指利用人工智慧平台分析從穿戴式裝置、數位裝置和臨床評估中收集的行為數據，以識別和描述與心理健康、認知功能和慢性疾病相關的模式。這些系統利用機器學習處理生理訊號、運動數據、社交互動和睡眠模式，從而創建隨時間推移的詳細行為特徵。行為表現型分析人工智慧應用於醫療保健、研究和職場健康領域，支持針對不同患者和用戶層的早期診斷、持續監測和個人化治療性介入。

全球精神健康危機正在惡化。

全球憂鬱症、焦慮症和認知障礙發病率的不斷上升，使得客觀的行為評估工具的需求變得迫切。人工智慧驅動的行為表現型分析能夠實現持續的被動監測，捕捉傳統臨床評估中常被忽略的行為指標。面臨診斷瓶頸的醫療系統正受惠於人工智慧輔助的分診和監測功能。製藥公司正在利用行為表現型分析數據來加速臨床試驗中的患者招募和終點測量。醫療保健需求與技術能力的這種整合是推動市場發展的動力。

倫理問題和監管不確定性

持續行為監測在知情同意、資料所有權和潛在濫用等方面引發了重大的倫理挑戰。包括 HIPAA 和 GDPR 在內的醫療隱私法規，為行為資料平台帶來了合規的複雜性。人們對保險和就業領域歧視性應用的擔憂，也引發了監管機構的審查。行為評估模型中的演算法偏差，有可能加劇醫療保健方面的不平等。這些倫理和監管方面的阻力，增加了研發成本，並延緩了臨床應用進程。

與穿戴式設備和數位健康平台整合

消費級穿戴裝置、智慧型手機和連網健康設備的普及，為人工智慧表現型分析平台提供了豐富的行為數據。行為分析公司與穿戴式裝置製造商之間的合作，正在建立一個強大的現實世界監測生態系統。從被動行為數據中發現數位生物標記物，正在改變臨床調查方法。在企業健康計畫中，行為監測正與更廣泛的健康參與平台整合。消費科技與臨床行為科學的融合，正在開啟巨大的新市場機會。

消費者和病患的強烈反對

隨著大眾對人工智慧行為監控應用的認知不斷提高，消費者的抵制情緒和要求加強監管的呼聲也日益高漲。圍繞情緒識別和行為追蹤的高調爭議，導致一些地區呼籲全面禁止此類應用。員工對職場行為監控的抵制，為實施相關技術的公司帶來了法律和勞動方面的風險。學術界對某些行為人工智慧技術科學有效性的爭論，正在削弱相關人員的信心。這些社會和政治阻力，為行為表現型人工智慧供應商的商業化進程帶來了巨大的不確定性。

新冠疫情的影響：

新冠疫情期間，隨著家庭對自動化、安全和遠端控制功能的日益重視，自主家居管理市場加速發展。受居家時間延長和人們對住宅舒適度日益成長的需求所推動，消費者紛紛投資人工智慧驅動的家庭監控、智慧家電和預測維修系統。物聯網連接和雲端控制平台的快速發展，也促進了自主解決方案的能源最佳化和運作效率的提升。這項轉變鞏固了全球市場對智慧自主家居生態系統的長期需求。

在預測期內，心理健康監測領域預計將佔據最大的市場佔有率。

預計在預測期內，心理健康監測領域將佔據最大的市場佔有率。這主要得益於全球心理健康狀況的改善以及人們對持續性、技術驅動的心理健康追蹤需求的日益成長的認知。醫療保健系統和雇主正在增加對人工智慧工具的投資，這些工具能夠透過行為數據檢測壓力、憂鬱症和焦慮的早期徵兆。該領域受益於強大的機構資金支持、不斷增加的臨床試驗以及全球範圍內對數位心理健康解決方案日益成長的接受度。

預計在預測期內，軟體領域將呈現最高的複合年成長率。

在預測期內，軟體領域預計將呈現最高的成長率。人工智慧驅動的分析平台是該市場的核心價值促進因素，能夠將原始行為數據轉化為可操作的臨床和健康洞察。隨著醫療服務提供者和研究機構加大對預測性醫療平台、訂閱式軟體模式和可互通的數位健康生態系統的投資，對先進行為表現型分析軟體的需求將持續成長，超越硬體和服務本身。

市佔率最大的地區：

在整個預測期內，亞太地區預計將保持最大的市場佔有率，這得益於其強大的醫療研究生態系統、美國國立衛生研究院 (NIH) 和私人機構對數位健康創新的大量資助，以及臨床人工智慧工具的高普及率。美國憑藉其廣泛的臨床試驗活動、不斷成長的心理健康技術市場和眾多數位健康平台，佔據主導地位。此外，有利於人工智慧健康工具的監管環境，以及眾多機構積極投資行為分析，進一步鞏固了該地區的領先地位。

複合年成長率最高的地區：

在預測期內，北美預計將呈現最高的複合年成長率。這主要得益於醫療基礎設施的快速擴張、人們對心理健康挑戰日益成長的認知，以及中國、日本、印度和韓國等國數位健康平台的日益普及，這些因素共同推動了對行為人工智慧解決方案的需求。政府主導的醫療數位化舉措和不斷成長的穿戴式科技市場將進一步鞏固該地區的強勁成長，使亞太地區成為行為表現型分析應用領域最具活力的成長區域。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要參與者（最多3家公司）的SWOT分析
  • 區域細分
    • 主要國家的市場估算和預測，以及根據客戶需求量身定做的複合年成長率（註：需要進行可行性測試）。
  • 競爭性標竿分析
    • 根據主要參與者的產品系列、地理覆蓋範圍和策略聯盟進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章：全球行為表現型分析人工智慧市場：按解決方案類型分類

  • 心理健康監測
  • 慢性病監測
  • 認知評估
  • 睡眠分析
  • 社會行為追蹤
  • 員工行為分析

第6章：全球行為表現型分析人工智慧市場：按組件分類

  • 軟體
  • 硬體
  • 服務

第7章：全球行為表現型分析人工智慧市場：依部署方式分類

  • 現場
  • 基於雲端的

第8章：全球行為表現型分析人工智慧市場：依技術分類

  • 機器學習
  • 自然語言處理
  • 電腦視覺
  • 穿戴式裝置整合

第9章：全球行為表現型分析人工智慧市場：按應用領域分類

  • 衛生保健
  • 臨床研究
  • 企業健康管理
  • 保險風險評估
  • 學術研究

第10章：全球行為表現型分析人工智慧市場：依最終使用者分類

  • 醫院
  • 研究機構
  • 製藥公司
  • 雇主
  • 保險公司

第11章 全球行為表現型分析人工智慧市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • IBM Corporation
  • Google LLC
  • Microsoft Corporation
  • Oracle Corporation
  • Amazon Web Services, Inc.
  • Apple Inc.
  • Fitbit, Inc.
  • Philips NV
  • Samsung Electronics Co., Ltd.
  • Cerner Corporation
  • Epic Systems Corporation
  • Siemens Healthineers AG
  • Medtronic plc
  • Roche Holding AG
  • Johnson & Johnson
  • Pfizer Inc.
  • Verily Life Sciences LLC
  • C3.ai, Inc.
Product Code: SMRC34175

According to Stratistics MRC, the Global Behavioral Phenotyping AI Market is accounted for $9.3 billion in 2026 and is expected to reach $28.1 billion by 2034 growing at a CAGR of 14.8% during the forecast period. Behavioral phenotyping AI refers to artificial intelligence platforms that analyze behavioral data collected from wearables, digital devices, and clinical assessments to identify and characterize patterns linked to mental health, cognitive function, and chronic disease. These systems use machine learning to process physiological signals, movement data, social interactions, and sleep patterns to create detailed behavioral profiles over time. Used in healthcare, research, and workplace wellness, behavioral phenotyping AI supports early diagnosis, continuous monitoring, and personalized therapeutic interventions across diverse patient and user populations.

Market Dynamics:

Driver:

Growing mental health crisis globally

Escalating rates of depression, anxiety, and cognitive disorders worldwide are creating urgent demand for objective behavioral assessment tools. AI behavioral phenotyping enables continuous, passive monitoring that captures behavioral indicators traditional clinical assessments miss. Healthcare systems facing diagnostic bottlenecks benefit from AI-assisted triage and monitoring capabilities. Pharmaceutical companies are leveraging behavioral phenotyping data to accelerate clinical trial recruitment and endpoint measurement. This convergence of healthcare need and technological capability is the primary market growth driver.

Restraint:

Ethical concerns and regulatory uncertainties

Continuous behavioral monitoring raises significant ethical questions about informed consent, data ownership, and potential misuse. Healthcare privacy regulations including HIPAA and GDPR create compliance complexity for behavioral data platforms. Concerns about discriminatory applications in insurance and employment contexts attract regulatory scrutiny. Algorithm bias in behavioral assessment models can perpetuate systemic healthcare disparities. These ethical and regulatory headwinds increase development costs and slow clinical adoption pathways.

Opportunity:

Integration with wearables and digital health platforms

The proliferation of consumer wearables, smartphones, and connected health devices generates rich behavioral data streams for AI phenotyping platforms. Partnerships between behavioral analytics companies and wearable device makers are creating powerful real-world monitoring ecosystems. Digital biomarker discovery from passive behavioral data is transforming clinical research methodologies. Employer wellness programs are integrating behavioral monitoring with broader health engagement platforms. This convergence of consumer technology and clinical behavioral science opens substantial new market opportunities.

Threat:

Consumer and patient backlash

Growing public awareness of AI behavioral monitoring applications is generating consumer backlash and advocacy for stronger regulatory protections. High-profile controversies around emotion recognition and behavioral tracking have prompted calls for outright bans in some jurisdictions. Employee resistance to workplace behavioral monitoring creates legal and labor relations risks for corporate adopters. Academic debates about the scientific validity of some behavioral AI claims undermine stakeholder confidence. These social and political headwinds create significant commercialization uncertainty for behavioral phenotyping AI providers.

Covid-19 Impact:

The Autonomous Home Management Market witnessed accelerated adoption during the COVID-19 period as households increasingly prioritized automation, security, and remote control capabilities. Spurred by prolonged stay-at-home trends and heightened focus on residential comfort, consumers invested in AI-enabled home monitoring, smart appliances, and predictive maintenance systems. Fueled by rapid advancements in IoT connectivity and cloud-based control platforms, autonomous solutions enhanced energy optimization and operational efficiency. This transformation reinforced long-term demand for intelligent, self-regulating home ecosystems across global markets.

The mental health monitoring segment is expected to be the largest during the forecast period

The mental health monitoring segment is expected to account for the largest market share during the forecast period, driven by the global rise in mental health conditions and growing recognition of the need for continuous, technology-enabled mental health tracking. Healthcare systems and employers are increasingly investing in AI tools that can detect early signs of stress, depression, and anxiety through behavioral data. The segment benefits from strong institutional funding, growing clinical trials, and expanding acceptance of digital mental health solutions worldwide.

The software segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the software segment is predicted to witness the highest growth rate, AI-powered analytics platforms are the core value driver in this market, transforming raw behavioral data into actionable clinical and wellness insights. As healthcare providers and research institutions invest in predictive health platforms, subscription-based software models, and interoperable digital health ecosystems, demand for sophisticated behavioral phenotyping software continues to accelerate beyond hardware and services.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share supported by a robust healthcare research ecosystem, significant NIH and private funding for digital health innovation, and high adoption of clinical AI tools. The United States leads with extensive clinical trial activity, a growing mental health technology market, and widespread digital health platform adoption. Favorable regulatory pathways for AI-based health tools and high institutional willingness to invest in behavioral analytics reinforce the region's dominant

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to, rapidly expanding healthcare infrastructure, rising awareness of mental health challenges, and increasing adoption of digital health platforms in China, Japan, India, and South Korea are driving demand for behavioral AI solutions. Government health digitalization initiatives and a growing wearable technology market further support strong regional growth, making Asia Pacific the most dynamically expanding geography for behavioral phenotyping applications.

Key players in the market

Some of the key players in Behavioral Phenotyping AI Market include IBM Corporation, Google LLC, Microsoft Corporation, Oracle Corporation, Amazon Web Services, Inc., Apple Inc., Fitbit, Inc., Philips N.V., Samsung Electronics Co., Ltd., Cerner Corporation, Epic Systems Corporation, Siemens Healthineers AG, Medtronic plc, Roche Holding AG, Johnson & Johnson, Pfizer Inc., Verily Life Sciences LLC, C3.ai, Inc.

Key Developments:

In February 2026, Microsoft introduced Azure AI Health Insights, embedding behavioral phenotyping capabilities into cloud platforms to enable hospitals and researchers to personalize care, predict patient outcomes, and optimize resource allocation.

In January 2026, IBM advanced Watson Health AI with behavioral phenotyping modules, integrating patient data analytics to support personalized treatment pathways, predictive diagnostics, and improved clinical decision-making in healthcare systems worldwide.

In December 2025, Google's Verily expanded behavioral phenotyping research, leveraging AI to analyze digital biomarkers from wearables and mobile platforms, aiming to enhance mental health monitoring, chronic disease management, and precision medicine initiatives.

Solution Types Covered:

  • Mental Health Monitoring
  • Chronic Disease Monitoring
  • Cognitive Assessment
  • Sleep Analysis
  • Social Behavior Tracking
  • Workforce Behavior Analytics

Components Covered:

  • Software
  • Hardware
  • Services

Deployments Covered:

  • On-Premise
  • Cloud-Based

Technologies Covered:

  • Machine Learning
  • Natural Language Processing
  • Computer Vision
  • Wearable Integration

Applications Covered:

  • Healthcare
  • Clinical Research
  • Corporate Wellness
  • Insurance Risk Assessment
  • Academic Research

End Users Covered:

  • Hospitals
  • Research Institutes
  • Pharmaceutical Companies
  • Employers
  • Insurance Providers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Behavioral Phenotyping AI Market, By Solution Type

  • 5.1 Mental Health Monitoring
  • 5.2 Chronic Disease Monitoring
  • 5.3 Cognitive Assessment
  • 5.4 Sleep Analysis
  • 5.5 Social Behavior Tracking
  • 5.6 Workforce Behavior Analytics

6 Global Behavioral Phenotyping AI Market, By Component

  • 6.1 Software
  • 6.2 Hardware
  • 6.3 Services

7 Global Behavioral Phenotyping AI Market, By Deployment

  • 7.1 On-Premise
  • 7.2 Cloud-Based

8 Global Behavioral Phenotyping AI Market, By Technology

  • 8.1 Machine Learning
  • 8.2 Natural Language Processing
  • 8.3 Computer Vision
  • 8.4 Wearable Integration

9 Global Behavioral Phenotyping AI Market, By Application

  • 9.1 Healthcare
  • 9.2 Clinical Research
  • 9.3 Corporate Wellness
  • 9.4 Insurance Risk Assessment
  • 9.5 Academic Research

10 Global Behavioral Phenotyping AI Market, By End User

  • 10.1 Hospitals
  • 10.2 Research Institutes
  • 10.3 Pharmaceutical Companies
  • 10.4 Employers
  • 10.5 Insurance Providers

11 Global Behavioral Phenotyping AI Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 IBM Corporation
  • 14.2 Google LLC
  • 14.3 Microsoft Corporation
  • 14.4 Oracle Corporation
  • 14.5 Amazon Web Services, Inc.
  • 14.6 Apple Inc.
  • 14.7 Fitbit, Inc.
  • 14.8 Philips N.V.
  • 14.9 Samsung Electronics Co., Ltd.
  • 14.10 Cerner Corporation
  • 14.11 Epic Systems Corporation
  • 14.12 Siemens Healthineers AG
  • 14.13 Medtronic plc
  • 14.14 Roche Holding AG
  • 14.15 Johnson & Johnson
  • 14.16 Pfizer Inc.
  • 14.17 Verily Life Sciences LLC
  • 14.18 C3.ai, Inc.

List of Tables

  • Table 1 Global Behavioral Phenotyping AI Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Behavioral Phenotyping AI Market Outlook, By Solution Type (2023-2034) ($MN)
  • Table 3 Global Behavioral Phenotyping AI Market Outlook, By Mental Health Monitoring (2023-2034) ($MN)
  • Table 4 Global Behavioral Phenotyping AI Market Outlook, By Chronic Disease Monitoring (2023-2034) ($MN)
  • Table 5 Global Behavioral Phenotyping AI Market Outlook, By Cognitive Assessment (2023-2034) ($MN)
  • Table 6 Global Behavioral Phenotyping AI Market Outlook, By Sleep Analysis (2023-2034) ($MN)
  • Table 7 Global Behavioral Phenotyping AI Market Outlook, By Social Behavior Tracking (2023-2034) ($MN)
  • Table 8 Global Behavioral Phenotyping AI Market Outlook, By Workforce Behavior Analytics (2023-2034) ($MN)
  • Table 9 Global Behavioral Phenotyping AI Market Outlook, By Component (2023-2034) ($MN)
  • Table 10 Global Behavioral Phenotyping AI Market Outlook, By Software (2023-2034) ($MN)
  • Table 11 Global Behavioral Phenotyping AI Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 12 Global Behavioral Phenotyping AI Market Outlook, By Services (2023-2034) ($MN)
  • Table 13 Global Behavioral Phenotyping AI Market Outlook, By Deployment (2023-2034) ($MN)
  • Table 14 Global Behavioral Phenotyping AI Market Outlook, By On-Premise (2023-2034) ($MN)
  • Table 15 Global Behavioral Phenotyping AI Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 16 Global Behavioral Phenotyping AI Market Outlook, By Technology (2023-2034) ($MN)
  • Table 17 Global Behavioral Phenotyping AI Market Outlook, By Machine Learning (2023-2034) ($MN)
  • Table 18 Global Behavioral Phenotyping AI Market Outlook, By Natural Language Processing (2023-2034) ($MN)
  • Table 19 Global Behavioral Phenotyping AI Market Outlook, By Computer Vision (2023-2034) ($MN)
  • Table 20 Global Behavioral Phenotyping AI Market Outlook, By Wearable Integration (2023-2034) ($MN)
  • Table 21 Global Behavioral Phenotyping AI Market Outlook, By Application (2023-2034) ($MN)
  • Table 22 Global Behavioral Phenotyping AI Market Outlook, By Healthcare (2023-2034) ($MN)
  • Table 23 Global Behavioral Phenotyping AI Market Outlook, By Clinical Research (2023-2034) ($MN)
  • Table 24 Global Behavioral Phenotyping AI Market Outlook, By Corporate Wellness (2023-2034) ($MN)
  • Table 25 Global Behavioral Phenotyping AI Market Outlook, By Insurance Risk Assessment (2023-2034) ($MN)
  • Table 26 Global Behavioral Phenotyping AI Market Outlook, By Academic Research (2023-2034) ($MN)
  • Table 27 Global Behavioral Phenotyping AI Market Outlook, By End User (2023-2034) ($MN)
  • Table 28 Global Behavioral Phenotyping AI Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 29 Global Behavioral Phenotyping AI Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 30 Global Behavioral Phenotyping AI Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
  • Table 31 Global Behavioral Phenotyping AI Market Outlook, By Employers (2023-2034) ($MN)
  • Table 32 Global Behavioral Phenotyping AI Market Outlook, By Insurance Providers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.